Sapiens International (SPNS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue reached $137 million, up 6.6% year-over-year, with strong growth in North America and Europe.
Net income rose 13.1% to $21 million, and diluted EPS increased 12.1% to $0.37.
Annualized recurring revenue (ARR) grew 12.1% year-over-year to $169 million.
Launched the Intelligent Insurance Platform with Microsoft, leveraging AI and SaaS capabilities.
Maintains global leadership in insurance software, serving 600+ customers across 38 countries.
Financial highlights
Q2 2024 gross margin was 45.7%, up 50 bps year-over-year; operating margin stable at 18.2%.
Adjusted free cash flow was $6.2 million, down from $12.1 million in Q2 2023.
Cash and cash equivalents stood at $186 million as of June 30, 2024.
Recurring software and post-production services revenue grew 18.7% to $98 million.
EPS was $0.37, up from $0.33 in Q2 2023.
Outlook and guidance
2024 non-GAAP revenue guidance reiterated at $550–$555 million, with operating margin of 18.1%–18.5%.
2024 operating profit expected to surpass $100 million.
Confident in meeting full-year guidance based on current performance and pipeline.
Latest events from Sapiens International
- Revenue and ARR grew, but net income and margins declined amid acquisitions and a pending buyout.SPNS
Q2 202515 Mar 2026 - Growth driven by cloud transition, M&A, and recurring revenue, with SaaS headwinds easing by 2026.SPNS
27th Annual Needham Growth Conference3 Feb 2026 - Q3 revenue up 4.8%, ARR at $173M, but 2024 guidance trimmed amid SaaS transition.SPNS
Q3 202415 Jan 2026 - 2024 revenue and profit rose, with 2025 targets focused on AI, cloud, and recurring growth.SPNS
Q4 202417 Dec 2025 - Q1 2025 delivered revenue growth, strong ARR, and acquisitions, with raised full-year guidance.SPNS
Q1 202519 Nov 2025 - Q3 2025 revenue grew 11.2% year-over-year, with a $2.5B acquisition agreement announced.SPNS
Q3 202513 Nov 2025